IntoCell Inc

Public

Daejeon, DaejeonBiotechhttps://intocell.com/

IntoCell Inc is now publicly traded

The data on this page reflects IntoCell Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

May 23, 2025

Last Round

Growth Equity

Aug 2, 2024

Est. Valuation at Exit

$167.09M

Total Funding Raised

$22.79M

Company Overview

IntoCell Inc is a biotechnology company that develops an antibody-drug conjugate (ADC) platform for the research and development of biopharmaceuticals.

Sector

Biotech

AI Layer

Non-AI

Keywords

antibody-drug conjugateADCADC platform technologypayload-linker platformADC linker technologyADC payload technologybioconjugationoncology biotechOHPAS linkerpayload modification technologyPMTbiotech licensingclinical stage biotechCDMO partnershipNexatecan payloadB7-H3 ADC

IntoCell Inc Comparables

Compare IntoCell Inc with similar companies based on industry and business-model similarity.

IntoCell Inc comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Pinotbio	84%
Novelty Nobility Inc.	83%
Aimed Bio Inc.	70%

View all Comparables

IntoCell Inc Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO	May 23, 2025
Growth Equity	Aug 2, 2024
Seed	Apr 1, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Yosup Rew

CTO Executive VP

Executive Team

Yosup Rew undefined

Chief Technology Officer

Executive Team

서영석

Chief Financial Officer

Executive Team

IntoCell Inc Investors

Notable investors and investment history

IntoCell Inc investors
Investor	Rounds
Mirae Asset Securities	IPO

View all Investors

IntoCell Inc Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

IntoCell Inc Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersDaejeon, Daejeon

Employee Range15

Year Founded2015

Last FundingAug 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?